Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Insulin for Cognitive Function After Cardiac Surgery
NCT03324867Unknown
- Sponsor
- McGill University Health Centre
- Start
- Apr 2022
- Primary completion
- Apr 2023
01
Overview
Randomised, double-blind trial of intranasal insulin in Post-operative cognitive dysfunction (POCD) and postoperative delirium (POD) (2 arms), sponsored by McGill University Health Centre. Primary endpoints: Confusion Assessment Method for the ICU at 5 days, Rey Auditory Verbal Learning at 12 months and 1 more. Status: unknown.
02
Drugs
intranasal insulin
03
Conditions
Post-operative cognitive dysfunction (POCD)postoperative delirium (POD)
Beyond the preview
Go deeper on NCT03324867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03324867.